C atheter ablation of atrial fibrillation (AF) has been shown to be more effective than antiarrhythmic drug therapy in maintaining sinus rhythm (1,2). Therefore current guidelines recommend AF catheter ablation as a class I therapy in symptomatic patients, refractory to antiarrhythmic drugs, and even consider it as first-line treatment of paroxysmal AF in the absence of structural heart disease (3-6). Based on the seminal findings of Haissaguerre et al. (7), who identified the pulmonary veins as a common site for focal triggers initiating AF, pulmonary vein isolation (PVI) currently presents the cornerstone of most AF ablation procedures (8).
C
atheter ablation of atrial fibrillation (AF) has been shown to be more effective than antiarrhythmic drug therapy in maintaining sinus rhythm (1, 2) . Therefore current guidelines recommend AF catheter ablation as a class I therapy in symptomatic patients, refractory to antiarrhythmic drugs, and even consider it as first-line treatment of paroxysmal AF in the absence of structural heart disease (3) (4) (5) (6) . Based on the seminal findings of Haissaguerre et al. (7), who identified the pulmonary veins as a common site for focal triggers initiating AF, pulmonary vein isolation (PVI) currently presents the cornerstone of most AF ablation procedures (8) .
However, PVI using a focal irrigated radiofrequency Interesting, but do these data provide final conclusions on the three methods under investigation?
Certainly not! This is due to a number of significant limitations that need to be recognized and consid- with greater efficacy and shorter ablation times (14) . In the current analysis only studies using the firstgeneration balloon were included. Also, IRF ablation was performed without contact force sensing catheters that go along with better outcomes (15, 16 
